Stockscreener 앱 받기
0.5851
2.49%
-0.0174
전일 마감가:
$0.6025
열려 있는:
$0.61
하루 거래량:
79,434
Relative Volume:
0.04
시가총액:
$3.05M
수익:
-
순이익/손실:
$-736.70K
주가수익비율:
-58.51
EPS:
-0.01
순현금흐름:
$-4.14M
1주 성능:
-11.32%
1개월 성능:
-26.56%
6개월 성능:
-41.83%
1년 성능:
-58.92%
1일 변동 폭
$0.5725
$0.6174
1주일 범위
$0.5725
$0.73
52주 변동 폭
$0.5725
$1.79
Xortx Therapeutics Inc Stock (XRTX) Company Profile
XRTX을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
XRTX
Xortx Therapeutics Inc
|
0.586 | 3.49M | 0 | -736.70K | -4.14M | -0.01 |
|
VRTX
Vertex Pharmaceuticals Inc
|
424.69 | 109.11B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
642.02 | 68.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
446.18 | 60.25B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
825.84 | 50.39B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
182.89 | 40.44B | 447.02M | -1.18B | -868.57M | -6.1812 |
Xortx Therapeutics Inc 주식(XRTX)의 최신 뉴스
Heatmap analysis for XORTX Therapeutics Inc. and competitorsJuly 2025 WrapUp & Free Long-Term Investment Growth Plans - newser.com
Is XORTX Therapeutics Inc. stock cheap at current valuation2025 Technical Overview & Safe Capital Growth Tips - newser.com
Statistical indicators supporting XORTX Therapeutics Inc.’s strengthJuly 2025 Volume & Technical Entry and Exit Tips - newser.com
Can XORTX Therapeutics Inc. stock sustain revenue growthProduct Launch & Safe Entry Trade Signal Reports - newser.com
What data driven models say about XORTX Therapeutics Inc.’s futureWeekly Trade Recap & Verified Swing Trading Watchlists - newser.com
How XORTX Therapeutics Inc. (ANUA) stock reacts to stronger dollar2025 Technical Patterns & Risk Adjusted Swing Trade Ideas - newser.com
Is XORTX Therapeutics Inc. stock entering bullish territoryIPO Watch & Target Return Focused Stock Picks - newser.com
Can XORTX Therapeutics Inc. stock attract ESG capital inflowsPortfolio Gains Summary & Safe Capital Growth Trade Ideas - newser.com
XORTX Therapeutics Completes $1.1 Million Direct Offering - MSN
Is XORTX Therapeutics Inc. forming a bottoming baseJuly 2025 Patterns & Community Supported Trade Ideas - newser.com
Is XORTX Therapeutics Inc. trending in predictive chart modelsEarnings Trend Report & Stepwise Trade Execution Plans - newser.com
Will XORTX Therapeutics Inc. stock see insider buyingJuly 2025 Price Swings & Weekly Breakout Stock Alerts - newser.com
Predicting XORTX Therapeutics Inc. trend using moving averages2025 Technical Overview & Reliable Breakout Forecasts - newser.com
Will XORTX Therapeutics Inc. bounce back from current support2025 Retail Activity & Target Return Focused Stock Picks - newser.com
Will XORTX Therapeutics Inc. stock gain from government policiesMarket Performance Recap & Weekly Stock Performance Updates - newser.com
Form 6-KReport of foreign issuer [Rules 13a-16 and 15d-16] - ADVFN
Order flow analysis tools used on XORTX Therapeutics Inc.Bull Run & Entry Point Confirmation Alerts - newser.com
Can XORTX Therapeutics Inc. stock reach $100 price targetMarket Sentiment Review & Free Safe Entry Trade Signal Reports - newser.com
Is XORTX Therapeutics Inc. (ANUA) stock attractive for growth funds2025 Fundamental Recap & Capital Protection Trade Alerts - newser.com
Can XORTX Therapeutics Inc. (ANUA) stock beat analyst consensusJuly 2025 Trends & Stepwise Trade Signal Implementation - newser.com
How to build a custom watchlist for XORTX Therapeutics Inc.Quarterly Trade Summary & Fast Entry High Yield Tips - newser.com
XORTX Therapeutics Inc. (XRTX) Stock Price | Live Quotes & Charts | NSC - StocksToTrade
XORTX Therapeutics Inc Stock Analysis and ForecastAnalyst Downgrades & Get Tomorrow’s Winners Today With AI - earlytimes.in
Vectus Biosystems Advances Strategic Partnerships and Licensing Opportunities - TipRanks
XORTX Therapeutics files to sell up to 4.76M shares - MSN
[6-K] XORTX Therapeutics Inc. Current Report (Foreign Issuer) - Stock Titan
Will XORTX Therapeutics Inc. stock maintain momentum in 2025Insider Buying & Low Risk Entry Point Guides - newser.com
XORTX Therapeutics Secures $1.1 Million in Direct Offering - TipRanks
XORTX Therapeutics Brief: Closed US$1.1 Million Registered Direct Offering - MarketScreener
XORTX Announces Closing of US$1.1 Million Registered Direct Offering - The Manila Times
Xortx Therapeutics Inc (XRTX) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.03%
0.32%
자본화:
|
볼륨(24시간):